Income Statement - Centessa Pharmaceuticals plc (CNTA)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | |
|---|---|---|---|---|---|---|---|
| Total revenue | 15.00 | 0.00 | 6.85 | 0.00 | 0.00 | 0.00 | |
| Cost of revenue | 0.94 | 0.81 | 0.13 | 0.03 | |||
| Gross profit | 15.00 | -0.94 | 6.85 | -0.13 | -0.03 | ||
| Total operating expenses | 222.69 | 201.06 | 178.14 | 212.26 | 374.87 | 10.44 | 5.05 |
| Operating income | -207.69 | -201.06 | -171.28 | -212.26 | -374.87 | -10.44 | -5.05 |
| Non-operating income (net) | 11.98 | -31.86 | -4.86 | -4.69 | -6.92 | -0.22 | -0.01 |
| Income before tax | -195.71 | -232.91 | -176.14 | -216.95 | -381.79 | -10.66 | -5.06 |
| Income tax expense | 1.82 | 2.84 | -25.06 | -0.75 | 0.11 | 0.38 | 0.22 |
| Net income | -197.53 | -235.76 | -151.09 | -216.21 | -381.90 | -10.66 | -5.28 |
Show Quarterly Income Statement
Income Statement - Centessa Pharmaceuticals plc (CNTA)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | Sep-22 | Jun-22 | Mar-22 | Dec-21 | Sep-21 | Jun-21 | Mar-21 | Dec-20 | Sep-20 | Jun-20 | Mar-20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0.00 | 0.00 | 0.00 | 0.00 | 15.00 | 0.95 | 0.00 | 0.00 | 0.00 | 6.85 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Cost of revenue | 0.24 | 0.23 | 0.22 | 0.48 | 0.24 | 0.24 | 0.24 | 0.25 | 0.24 | 0.24 | 0.09 | 0.04 | 0.03 | 0.03 | 0.03 | 0.01 | 0.01 | 0.00 | |||||||
| Gross profit | -0.24 | -0.23 | 15.00 | 0.48 | -0.24 | -0.24 | -0.24 | 6.85 | -0.24 | -0.24 | -0.09 | -0.04 | -0.03 | -0.03 | -0.03 | 0.01 | -0.01 | 0.00 | |||||||
| Total operating expenses | 79.77 | 68.47 | 53.79 | 54.65 | 45.78 | 74.58 | 46.41 | 43.98 | 36.09 | 42.03 | 40.21 | 47.02 | 48.88 | 41.60 | 49.03 | 68.41 | 53.22 | 54.52 | 38.31 | 41.29 | 236.97 | 3.01 | 2.12 | 2.13 | 3.19 |
| Operating income | -79.77 | -68.47 | -53.79 | -54.65 | -30.78 | -74.58 | -46.41 | -43.98 | -36.09 | -35.18 | -40.21 | -47.02 | -48.88 | -41.60 | -49.03 | -68.41 | -53.22 | -58.29 | -38.31 | -41.29 | -236.97 | -3.01 | -2.12 | -2.13 | -3.19 |
| Non-operating income (net) | 1.38 | 1.79 | -0.94 | 5.09 | 6.04 | -35.70 | 4.45 | 0.87 | -1.48 | -0.52 | -1.27 | -1.92 | -1.16 | -2.23 | -4.99 | 3.73 | -1.20 | -2.37 | -1.84 | -0.16 | -2.55 | -0.28 | -0.02 | -0.10 | 0.18 |
| Income before tax | -78.39 | -66.69 | -54.73 | -49.57 | -24.74 | -110.28 | -41.96 | -43.11 | -37.57 | -35.69 | -41.47 | -48.94 | -50.04 | -43.84 | -54.02 | -64.68 | -54.42 | -60.66 | -40.16 | -41.45 | -239.52 | -3.29 | -2.14 | -2.23 | -3.01 |
| Income tax expense | 0.85 | -0.52 | 0.17 | 0.78 | 1.40 | 1.05 | 0.61 | 0.71 | 0.48 | 1.14 | -2.83 | -24.05 | 0.68 | -0.66 | -0.14 | -0.02 | 0.08 | 0.11 | -0.07 | -11.34 | 0.00 | -0.02 | -0.10 | 0.18 | |
| Net income | -79.24 | -66.16 | -54.89 | -50.34 | -26.14 | -111.33 | -42.57 | -43.82 | -38.05 | -36.84 | -38.65 | -24.89 | -50.71 | -43.17 | -53.88 | -64.66 | -54.50 | -60.77 | -40.16 | -41.45 | -239.52 | -3.29 | -2.14 | -2.23 | -3.01 |